| James Robert Powell, MD | |
|
1025 Center St, Samaritan Regional Health System, Ashland, OH 44805-4011 | |
| (419) 289-0491 | |
| (419) 207-2611 |
| Full Name | James Robert Powell |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 1025 Center St, Ashland, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396718672 | NPI | - | NPPES |
| 2727722 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 35089459 (Ohio) | Primary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD02934OE (Pennsylvania) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| James Robert Powell, MD Po Box 72098, Samaritan Regional Health System, Cleveland, OH 44192-0002 Ph: (513) 557-3195 | James Robert Powell, MD 1025 Center St, Samaritan Regional Health System, Ashland, OH 44805-4011 Ph: (419) 289-0491 |
News Archive
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, and FBM Industria Farmaceutica Ltda, a member of the HOSPFAR Group that manufactures, imports and distributes pharmaceuticals in Brazil, today announced a license and distribution agreement providing FMBFarma exclusive rights to market Zertane in Brazil for the treatment of premature ejaculation.
When it comes to meeting national health goals for physical activity, Mexican-Americans are the most active group in America and may benefit from exercise that researchers typically have not measured, according to research by scholars at the University of Chicago and Arizona State University.
UC Santa Barbara's Institute for Collaborative Biotechnologies has received an extension of its contract with the U.S. Army Research Laboratory-Army Research Office, providing an additional $48 million over three years to support research that is inspired by biological systems. The continuation in ICB funding speaks to the success of a decade of fundamental research in the areas of biotechnology, chemistry, engineering, physics, materials science, computer science, neuroscience and medicine.
Asklepion Pharmaceuticals, LLC. today announced that the U.S. Food and Drug Administration (FDA) approved CHOLBAM (cholic acid) as a once-daily treatment for cholic acid deficiency in bile acid synthesis disorders due to single enzyme defects.
A new study published in the December issue of The American Journal of Medicine shows a significant association between low dietary fiber intake and cardiometabolic risks including metabolic syndrome, cardiovascular inflammation, and obesity.
› Verified 9 days ago
Faranak Zarrabi, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2021 Baney Rd S Ste A, Ashland, OH 44805 Phone: 419-289-1133 Fax: 419-289-1132 | |
Zeeshan Hussain, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 350 Hillcrest Dr, Ashland, OH 44805 Phone: 419-289-9800 | |
Young Shin, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2111 Claremont Ave, Ashland, OH 44805 Phone: 419-281-5575 Fax: 419-289-1677 | |
Angela M Novy, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 934 Center St, Miller Building Suite C, Ashland, OH 44805 Phone: 419-281-2222 | |
Dr. Yulanka Stephany Castro-dominguez, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 350 Hillcrest Dr, Ashland, OH 44805 Phone: 419-289-9800 | |
Dr. Mehrdad Tavallaee, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2021 Baney Rd S Ste A, Ashland, OH 44805 Phone: 419-289-1133 Fax: 419-289-1132 |